Evaluations
After completing your CE course, please fill out the equivalent evaluation form by clicking on one of the links below.
2022
June 15
Long COVID: Persistent Complications of an Acute Infection
Joseph V. Etzel, Pharm.D. Associate Dean for Student Success,
Associate Clinical Professor Department of Clinical Health Professions College of Pharmacy and Health Sciences,
St. John’s University Jamaica, NY
May 18
Government Affairs Update: Key Health Policy Issues
Brad Kile, PhD – President, Dumbarton Group, LLC, Washington DC
Shara Siegel, MS – Director of Government Affairs, Premier Inc.
April 13
Antibiotic Stewardship in Long-Term Care
Kati Shihadeh, PharmD, BCIDP Clinical Pharmacy Specialist – Infectious Diseases PGY2 Infectious Diseases Residency Program Director Denver Health Medical Center Denver, CO
March 16
A Breath of Fresh Air: Updates with the Management of Asthma
Alexa A. Carlson, PharmD, MEd, BCPS
Associate Clinical Professor, Department of Pharmacy & Health Systems Sciences
School of Pharmacy | Bouvé College of Health Sciences
Northeastern University, Boston, MA
Ryan M. Seagren, PharmD, BCPPS
Pediatric Clinical Pharmacist
American Family Children’s Hospital | UWHealth, Madison, WI
February 16
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and Specialty/Oncology Drug Pipeline in 2022-2023
Liya Davydov, Pharm.D., BCPS, BCGP
Senior Director, Clinical Pharmacy Services,
Director, Drug Intelligence
Innovatix (Premier)
New York, NY
January 19
Government Affairs Update: Key Health Policy Issues for 2022
Brad Kile, PhD – President Dumbarton Group, LLC, Washington DC
Shara Siegel, MS – Director of Government Affairs Premier Alternate Site
2021
December 15
ASCP Choosing Wisely Statements with Focus on Reducing Anticholinergic Burden in Older Adults
Manju T Beier, Pharm D., BCGP, FASCP
President of Geriatric Consultant Resources LLC
Adjunct Associate Professor of Pharmacy
The University of Michigan, Ann Arbor, MI
November 17
What’s the Latest and Greatest for the Treatment of Heart Failure
Joseph J. Saseen, PharmD
Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical
Pharmacy/Professor; Department of Family Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Aurora, CO
October 27
Primer on Oncology Palliative Care
J. Andrew Orr-Skirvin, BS Pharm, PharmD, BCOP, RPh
Department Chair, Department of Pharmacy & Health System Sciences
Pharmaceutical Industry Fellowship Program Director
Clinical Professor
Bouve College of Health Sciences & School of Pharmacy
Boston, MA
September 14
Government Affairs Update: Key Health Policy Issues for the Remainder of 2021
Brad Kile, PhD – President Dumbarton Group, LLC, Washington DC
Shara Siegel, MS – Director of Government Affairs Premier Alternate Site
August 11
Monoclonal Antibodies in the Treatment of COVID-19
Kati Shihadeh, PharmD, BCIDP
Clinical Pharmacy Specialist – Infectious Diseases
PGY2 Infectious Diseases Residency Program Director
Denver Health Medical Center
Denver, CO
July 14
COVID-19 Vaccines: Facts, Fiction, and Possible Futures
Douglas Fish, Pharm.D.
Professor and Chair, Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Aurora, CO
June 23
Compounding Update: USP <797>, USP <800>, and NIOSH Hazardous Drug List
Patricia C. Kienle, RPh, MPA, BCSCP, FASHP
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Solutions
Stafford, TX
May 26
Government Affairs Update: The 2021 Health Policy Agenda, Payment Proposals and Compliance Trends for Providers Leigh Davitian, JD – CEO and Brad Kile, PhD – President Dumbarton Group, LLC, Washington DC
Shara Siegel, MS – Director of Government Affairs Premier Alternate Site
April 14
Safe and Effective Vaccination “Catch-Up” Schedules During a Global Pandemic
Alexa A. Carlson, PharmD, MEd, BCPS
Associate Clinical Professor, Department of Pharmacy & Health Systems Sciences
School of Pharmacy | Bouvé College of Health Sciences
Northeastern University, Boston, MA
Ryan M. Seagren, PharmD, BCPPS
Pediatric Clinical Pharmacist
American Family Children’s Hospital | UWHealth, Madison, WI
March 24
Evidence-Based Strategies to Treat Hypertension in Older Patients
Joseph J. Saseen, PharmD Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy/Professor; Department of Family Medicine Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Aurora, CO
February 24
Government Affairs Update: Key Health Policy Issues for 2021
Leigh Davitian, JD – CEO and Brad Kile, PhD – President Dumbarton Group, LLC, Washington DC
Soumi Saha, PharmD, JD – Vice President of Advocacy Premier, Inc
January 20
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and Specialty/Oncology Drug Pipeline in 2021-2022
Liya Davydov, Pharm.D., BCPS, BCGP, Vice President, Clinical Pharmacy Services, Innovatix (Premier)
2020
December 16
Enhancing Patient Engagement and Patient Satisfaction
Kelly Haskard-Zolnierek, Ph.D., Associate Professor of Psychology, Texas State University, San Marcos, TX
November 18
Like a Breath of Fresh Air: Updates in the Management of Community-Acquired Pneumonia
Douglas Fish, Pharm.D.
Professor and Chair, Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Aurora, CO
October 21
Two for One Pharmacotherapy Approaches for Type 2 Diabetes: Managing Both Hyperglycemia and CV Risk
Joseph J. Saseen, PharmD Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy/Professor; Department of Family Medicine Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Aurora, CO
September 16
Government Affairs Update: Key Health Policy Issues for the Remainder of 2020
Brad Kile, PhD – President Dumbarton Group, LLC, Washington DC
Soumi Saha, PharmD, JD – Senior Director of Advocacy Premier, Inc
Shara Siegel, MS – Director of Government Affairs Premier Alternate Site
August 12
Management of ABSSSI secondary to MRSA
Toral Patel, PharmD, BCPS
Assistant Professor, Department of Clinical Pharmacy | University of Colorado Anschutz
Medical Campus
Clinical Pharmacy Specialist & Experiential Liaison | University of Colorado Hospital
Aurora, CO
July 15
Drug-drug and drug-disease interaction potential of cannabis
Joshua Brown, PharmD, PhD, MS
Assistant Professor and Associate Graduate Program Director
Pharmaceutical Outcomes & Policy
University of Florida College of Pharmacy
Gainesville, FL
June 17
Best Practices for Compounding Standards: <795>,<797>, <800>, and <825>
Patricia C. Kienle, MPA, BCSCP, FASHP
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Solutions
Stafford, TX
May 13
Government Affairs Update: COVID-19 Policy Updates and CMS Payment Proposals
Brad Kile, PhD – President, Dumbarton Group, LLC,
Leigh Davitian, JD, – CEO, Dumbarton Group, LLC,
Soumi Saha, PharmD, JD – Senior Director of Advocacy, Premier,
Shara Siegel, MS – Director of Government Affairs, Premier Alternate Site Programs.
April 22
Nutritional Management in The Oncology Patient, Review of Enteral/Parenteral Nutrition
J. Andrew Orr-Skirvin, Pharm. D., BCOP
Department Chair, Department of Pharmacy & Health System Sciences
Pharmaceutical Industry Fellowship Program Director
Associate Clinical Professor, Bouve College of Health Sciences & School of Pharmacy, Boston, MA
March 11
Time to Deprescribe in Older Adults: Tools and Progress Made
Manju T Beier, Pharm D., BCGP, FASCP
Senior Partner, Geriatric Consultant Resources, LLC
Adjunct Associate Professor of Pharmacy, The University of Michigan, Ann Arbor, MI
February 19
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and Specialty/Oncology Drug Pipeline in 2020-2021
Liya Davydov, Pharm.D., BCPS, BCGP
January 22
Government Affairs Update: 2020 Health Policy Agenda and the Impact on Providers
Brad Kile, PhD – President, Dumbarton Group, LLC, Soumi Saha, PharmD, JD – Senior Director of Advocacy, Premier and Shara Siegel, MS – Director of Government Affairs, Premier Alternate Site
2019
December 11
The 2018 Cholesterol Guidelines and Beyond: PCSK9 Inhibitors and Omega-3 Fatty Acids
Joseph J. Saseen, PharmD
November 13
Pharmacologic Management of Osteoarthritis (OA)
Maha Saad, PharmD, BCGP, BCPS
October 16
Wound Care in the Elderly: How can Wound Healing be Achieved?
Antonia Alafris, B.S., Pharm.D., BCGP
August 14
An Update On Gout
Alexa A. Carlson, PharmD, BCPS
July 16
Preparing Your Pharmacy for Updated Compounding Standards: 795, 797, 800, and 825
Patricia C. Kienle, RPh, MPA, FASHP
June 12
Parenteral Nutrition Tenets
Phil Ayers, BS, PharmD, BCNSP, FASHP
May 22
Government Affairs Update: The 2019 Health Policy Agenda, Payment Proposals and Compliance Trends for Providers
Leigh Davitian, JD & Brad Kile, PhD – President, Dumbarton Group, LLC and Shara Siegel, MS – Director of Government Affairs, Innovatix
April 10
Go On, (Don’t) Leave me Breathless: An Update on COPD
Alexa A. Carlson, PharmD, BCPS
March 13
Update on the AGS Beers Criteria and Medication Safety Considerations in Older Adults
Judith L. Beizer, PharmD, BCGP, FASCP, AGSF
February 13
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and
Specialty/Oncology Drug Pipeline in 2019-2020
Liya Davydov, Pharm.D., BCPS, BCGP
January 16
Government Affairs Update: 2019 Health Policy Agenda and the Impact on Providers
Leigh Davitian, JD & Brad Kile, PhD – President, Dumbarton Group, LLC and Shara Siegel, MS – Director of Government Affairs, Innovatix
2018
December 12
Late Life Depression Treatment Considerations: What’s New and Deserving?
Manju T Beier, Pharm D., BCGP, FASCP
November 14
Balancing Unpredictable Intravenous Medication Supply with the Demand for Safe Injection Practices
Matthew Grissinger, RPh, FISMP, FASCP
October 17
Marijuana Use: A Friend or Foe for Older Adults?
Danielle Fixen, PharmD, BCGP, BCPS
September 12
Government Affairs Update: Key Health Policy Issues Heading into the 2018 Election
Brad Kile, PhD – President, Dumbarton Group, LLC & Shara Siegel, MS – Director of Government Affairs, Innovatix
August 15
Update on the Management of Patients with Ovarian Cancer
J. Andrew Skirvin, PharmD, BCOP
July 18
Herpes Zoster (Shingles) Vaccine: Out with the Old and In with the New
Danielle Fixen, PharmD, BCGP, BCPS
June 13
Focus on Medication Errors: Essential Strategies to Ensure Safe Opioid Use
Matthew Grissinger, RPh, FISMP, FASCP
May 16
Government Affairs Update: 2018 Health Policy Agenda Status and Compliance Trends for Providers
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC & Shara Siegel, MS – Director of Government Affairs, Innovatix
April 17
Using Novel Technologies to Prevent Catheter Infection
Felicia Schaps RN, MSN-Ed, CRNI, OCN, CNSC, IgCN
March 14
Update on the Management of Hypertension in Older Patients
Joseph Saseen, PharmD, BCPS, BCACP
February 14
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and
Specialty/Oncology Drug Pipeline in 2018-2019
Liya Davydov, Pharm.D., BCPS, BCGP
January 17
Government Affairs Update: 2018 Health Policy Agenda
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC
2017
December 5
CMS Final Rule Pharmacy Services Update: What You Need to Know!
William C. Hallett, Pharm. D., MBA, BCGP, C-MTM
November 15
Direct to Consumer Genetic Testing: Navigating the Hope and Hype
Manju T Beier, Pharm D., BCGP, FASCP
October 18
USP <800>: Completing an Assessment of Risk
Patricia C. Kienle, RPh, MPA, FASHP
September 13
Government Affairs Update: Medicare Payment Issues and Medicaid Program Integrity
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC, Shara Siegel, MS Director of Government Affairs, Innovatix
August 16
Update on Rheumatoid Arthritis and an Introduction to Psoriatic Arthritis Management
J. Andrew Skirvin, PharmD, BCOP
July 12
Update on the Management of Non-Small Cell Lung Cancer
J. Andrew Skirvin, PharmD, BCOP
June 21
Health Policy Update: What to Expect for 2017 and Beyond
Brad Kile, PhD – President, Dumbarton Group, LLC
May 17
Government Affairs Update: Medicare Payment Reform and New Compliance Trends for Providers
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC, Shara Siegel, MS Director of Government Affairs, Innovatix
April 20
New Therapeutic Options for the Management of Diabetes
Michael P. Kane, PharmD, FCCP, BCPS, BCACP
March 15
What Lies Ahead – A Look at the Specialty, Infusion and Biosimilar Drug Pipeline in 2017 – 2018
Liya Davydov, Pharm.D., BCPS, CGP
February 15
USP Chapter 800 Hazardous Drug Handling: What Healthcare Providers Need to Know
Martha Polovich, PhD, RN, AOCN
January 18
Government Affairs Update: 2017 Health Policy Agenda and Impact on Providers
Brad Kile, PhD & Shara Siegel, MS
2019
August 14
An Update On Gout
Alexa A. Carlson, PharmD, BCPS
July 16
Preparing Your Pharmacy for Updated Compounding Standards: 795, 797, 800, and 825
Patricia C. Kienle, RPh, MPA, FASHP
June 12
Parenteral Nutrition Tenets
Phil Ayers, BS, PharmD, BCNSP, FASHP
May 22
Government Affairs Update: The 2019 Health Policy Agenda, Payment Proposals and Compliance Trends for Providers
Leigh Davitian, JD & Brad Kile, PhD – President, Dumbarton Group, LLC and Shara Siegel, MS – Director of Government Affairs, Innovatix
April 10
Go On, (Don’t) Leave me Breathless: An Update on COPD
Alexa A. Carlson, PharmD, BCPS
March 13
Update on the AGS Beers Criteria and Medication Safety Considerations in Older Adults
Judith L. Beizer, PharmD, BCGP, FASCP, AGSF
February 13
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and
Specialty/Oncology Drug Pipeline in 2019-2020
Liya Davydov, Pharm.D., BCPS, BCGP
January 16
Government Affairs Update: 2019 Health Policy Agenda and the Impact on Providers
Leigh Davitian, JD & Brad Kile, PhD – President, Dumbarton Group, LLC and Shara Siegel, MS – Director of Government Affairs, Innovatix
2018
December 12
Late Life Depression Treatment Considerations: What’s New and Deserving?
Manju T Beier, Pharm D., BCGP, FASCP
November 14
Balancing Unpredictable Intravenous Medication Supply with the Demand for Safe Injection Practices
Matthew Grissinger, RPh, FISMP, FASCP
October 17
Marijuana Use: A Friend or Foe for Older Adults?
Danielle Fixen, PharmD, BCGP, BCPS
September 12
Government Affairs Update: Key Health Policy Issues Heading into the 2018 Election
Brad Kile, PhD – President, Dumbarton Group, LLC & Shara Siegel, MS – Director of Government Affairs, Innovatix
August 15
Update on the Management of Patients with Ovarian Cancer
J. Andrew Skirvin, PharmD, BCOP
July 18
Herpes Zoster (Shingles) Vaccine: Out with the Old and In with the New
Danielle Fixen, PharmD, BCGP, BCPS
June 13
Focus on Medication Errors: Essential Strategies to Ensure Safe Opioid Use
Matthew Grissinger, RPh, FISMP, FASCP
May 16
Government Affairs Update: 2018 Health Policy Agenda Status and Compliance Trends for Providers
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC & Shara Siegel, MS – Director of Government Affairs, Innovatix
April 17
Using Novel Technologies to Prevent Catheter Infection
Felicia Schaps RN, MSN-Ed, CRNI, OCN, CNSC, IgCN
March 14
Update on the Management of Hypertension in Older Patients
Joseph Saseen, PharmD, BCPS, BCACP
February 14
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and
Specialty/Oncology Drug Pipeline in 2018-2019
Liya Davydov, Pharm.D., BCPS, BCGP
January 17
Government Affairs Update: 2018 Health Policy Agenda
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC
2017
December 5
CMS Final Rule Pharmacy Services Update: What You Need to Know!
William C. Hallett, Pharm. D., MBA, BCGP, C-MTM
November 15
Direct to Consumer Genetic Testing: Navigating the Hope and Hype
Manju T Beier, Pharm D., BCGP, FASCP
October 18
USP <800>: Completing an Assessment of Risk
Patricia C. Kienle, RPh, MPA, FASHP
September 13
Government Affairs Update: Medicare Payment Issues and Medicaid Program Integrity
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC, Shara Siegel, MS Director of Government Affairs, Innovatix
August 16
Update on Rheumatoid Arthritis and an Introduction to Psoriatic Arthritis Management
J. Andrew Skirvin, PharmD, BCOP
July 12
Update on the Management of Non-Small Cell Lung Cancer
J. Andrew Skirvin, PharmD, BCOP
June 21
Health Policy Update: What to Expect for 2017 and Beyond
Brad Kile, PhD – President, Dumbarton Group, LLC
May 17
Government Affairs Update: Medicare Payment Reform and New Compliance Trends for Providers
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC, Shara Siegel, MS Director of Government Affairs, Innovatix
April 20
New Therapeutic Options for the Management of Diabetes
Michael P. Kane, PharmD, FCCP, BCPS, BCACP
March 15
What Lies Ahead – A Look at the Specialty, Infusion and Biosimilar Drug Pipeline in 2017 – 2018
Liya Davydov, Pharm.D., BCPS, CGP
February 15
USP Chapter 800 Hazardous Drug Handling: What Healthcare Providers Need to Know
Martha Polovich, PhD, RN, AOCN
January 18
Government Affairs Update: 2017 Health Policy Agenda and Impact on Providers
Brad Kile, PhD & Shara Siegel, MS
2019
August 14
An Update On Gout
Alexa A. Carlson, PharmD, BCPS
July 16
Preparing Your Pharmacy for Updated Compounding Standards: 795, 797, 800, and 825
Patricia C. Kienle, RPh, MPA, FASHP
June 12
Parenteral Nutrition Tenets
Phil Ayers, BS, PharmD, BCNSP, FASHP
May 22
Government Affairs Update: The 2019 Health Policy Agenda, Payment Proposals and Compliance Trends for Providers
Leigh Davitian, JD & Brad Kile, PhD – President, Dumbarton Group, LLC and Shara Siegel, MS – Director of Government Affairs, Innovatix
April 10
Go On, (Don’t) Leave me Breathless: An Update on COPD
Alexa A. Carlson, PharmD, BCPS
March 13
Update on the AGS Beers Criteria and Medication Safety Considerations in Older Adults
Judith L. Beizer, PharmD, BCGP, FASCP, AGSF
February 13
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and
Specialty/Oncology Drug Pipeline in 2019-2020
Liya Davydov, Pharm.D., BCPS, BCGP
January 16
Government Affairs Update: 2019 Health Policy Agenda and the Impact on Providers
Leigh Davitian, JD & Brad Kile, PhD – President, Dumbarton Group, LLC and Shara Siegel, MS – Director of Government Affairs, Innovatix
2018
December 12
Late Life Depression Treatment Considerations: What’s New and Deserving?
Manju T Beier, Pharm D., BCGP, FASCP
November 14
Balancing Unpredictable Intravenous Medication Supply with the Demand for Safe Injection Practices
Matthew Grissinger, RPh, FISMP, FASCP
October 17
Marijuana Use: A Friend or Foe for Older Adults?
Danielle Fixen, PharmD, BCGP, BCPS
September 12
Government Affairs Update: Key Health Policy Issues Heading into the 2018 Election
Brad Kile, PhD – President, Dumbarton Group, LLC & Shara Siegel, MS – Director of Government Affairs, Innovatix
August 15
Update on the Management of Patients with Ovarian Cancer
J. Andrew Skirvin, PharmD, BCOP
July 18
Herpes Zoster (Shingles) Vaccine: Out with the Old and In with the New
Danielle Fixen, PharmD, BCGP, BCPS
June 13
Focus on Medication Errors: Essential Strategies to Ensure Safe Opioid Use
Matthew Grissinger, RPh, FISMP, FASCP
May 16
Government Affairs Update: 2018 Health Policy Agenda Status and Compliance Trends for Providers
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC & Shara Siegel, MS – Director of Government Affairs, Innovatix
April 17
Using Novel Technologies to Prevent Catheter Infection
Felicia Schaps RN, MSN-Ed, CRNI, OCN, CNSC, IgCN
March 14
Update on the Management of Hypertension in Older Patients
Joseph Saseen, PharmD, BCPS, BCACP
February 14
What Lies Ahead – A Look at the Biosimilar, Infectious Diseases and
Specialty/Oncology Drug Pipeline in 2018-2019
Liya Davydov, Pharm.D., BCPS, BCGP
January 17
Government Affairs Update: 2018 Health Policy Agenda
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC
2017
December 5
CMS Final Rule Pharmacy Services Update: What You Need to Know!
William C. Hallett, Pharm. D., MBA, BCGP, C-MTM
November 15
Direct to Consumer Genetic Testing: Navigating the Hope and Hype
Manju T Beier, Pharm D., BCGP, FASCP
October 18
USP <800>: Completing an Assessment of Risk
Patricia C. Kienle, RPh, MPA, FASHP
September 13
Government Affairs Update: Medicare Payment Issues and Medicaid Program Integrity
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC, Shara Siegel, MS Director of Government Affairs, Innovatix
August 16
Update on Rheumatoid Arthritis and an Introduction to Psoriatic Arthritis Management
J. Andrew Skirvin, PharmD, BCOP
July 12
Update on the Management of Non-Small Cell Lung Cancer
J. Andrew Skirvin, PharmD, BCOP
June 21
Health Policy Update: What to Expect for 2017 and Beyond
Brad Kile, PhD – President, Dumbarton Group, LLC
May 17
Government Affairs Update: Medicare Payment Reform and New Compliance Trends for Providers
Leigh Davitian, JD – CEO and Brad Kile, PhD – President, Dumbarton Group, LLC, Shara Siegel, MS Director of Government Affairs, Innovatix
April 20
New Therapeutic Options for the Management of Diabetes
Michael P. Kane, PharmD, FCCP, BCPS, BCACP
March 15
What Lies Ahead – A Look at the Specialty, Infusion and Biosimilar Drug Pipeline in 2017 – 2018
Liya Davydov, Pharm.D., BCPS, CGP
February 15
USP Chapter 800 Hazardous Drug Handling: What Healthcare Providers Need to Know
Martha Polovich, PhD, RN, AOCN
January 18
Government Affairs Update: 2017 Health Policy Agenda and Impact on Providers
Brad Kile, PhD & Shara Siegel, MS
2021
Closing General Session: Clinical Keynote
The COVID-19 Pandemic: Where Are We Nearly Two Years Later?
Douglas N. Fish, PharmD, FCCM, FCCP, FIDP, FASHP, BCCCP
Program 1A
Choosing Medications Wisely: A Deprescribing Drive to Educate and Implement
Manju T. Beier, Pharm D., BCGP, FASCP
Program 1B
Legislative & Regulatory Update: Shifting Payments and the Movement Towards Home Health
Shara Siegel, MS
Brad Kile, PhD
Program 1C
Sustaining Your Resilience During Challenging Times
Phyllis Quinlan, PhD, RN, NPD-BC
Program 2A
New Medications for LDL-C Lowering
Dr. Joseph Saseen, PharmD
Program 2B
Infection Prevention and Technology: Challenges and Opportunities in Long-Term / Post-Acute Care Panel
Daisy Jackson, CIC
Jocelyn Thomas, MPH, CIC, CLSSGB
Linda Behan, BSN, RN, CIC
Program 3A
Antibiotic Stewardship in Long-Term Care
Dr. Kati Shihadeh, PharmD, BCIDP
Program 3B
Emerging Risks of Noncompliance: The Nuts and Bolts of Avoiding a Disastrous Audit in Alternate Sites
S. Leigh Davitian, JD
Program 3C
Building the Aquarium: Creating the Environment for Diversity, Equity, Inclusion and Belonging
Joseph Machicote
2020
June
Biosimilars in the US: Where Are We Now?
2019
Spring
Prevention and Management of Clostridioides Difficile Infection (CDI) in Adults
2018
Fall
Update on the Management of Rheumatoid Arthritis in Adults
Spring
Heart Failure: A Guideline Directed Medical Therapy Approach to Diagnosis and Treatment
2017
Fall
Update on Biosimilars – Current Status in the USA
Spring
Rethinking Warfarin: Time to Change the Dose, or Change the Drug?
2016
Issue 2
Antibiotic Stewardship in Nursing Facilities – What Should You Know?
Winter
Advances in Therapy for Management of Methicillin-resistant Staphylococcus aureus (MRSA) infections
2022
Educational Sessions from the 2021 Premier Alternate Site Programs Virtual National Meeting & Expo:
Choosing Medications Wisely: A Deprescribing Drive to Educate and Implement
Manju T Beier, Pharm D., BCGP, FASCP
- Recorded Webcast
- PowerPoint Presentation
- ACPE Evaluation Links:
Legislative & Regulatory Update: Shifting Payments and the Movement Towards Home Health
Shara Siegel, MS, Director of Government Affairs, Premier
Brad Kile Brad Kile, PhD President, Dumbarton Group
- Recorded Webcast
- PowerPoint Presentation
- ACPE Evaluation Links:
New Medications for LDL-C Lowering
Joseph Saseen, PharmD, Professor and Associate Dean for Clinical Affairs, University of Colorado Anschutz Medical Campus
- Recorded Webcast
- PowerPoint Presentation
- ACPE Evaluation Links:
Antibiotic Stewardship in Long-Term Care
Kati Shihadeh, PharmD, BCIDP, Infectious Diseases Pharmacy Specialist, Denver Health Medical Center
- Recorded Webcast
- PowerPoint Presentation
- ACPE Evaluation Links:
Emerging Risks of Noncompliance: The Nuts and Bolts of Avoiding a Disastrous Audit in Alternate Sites
Leigh Davitian, JD, Chief Executive Officer, Dumbarton Group
- Recorded Webcast
- PowerPoint Presentation
- ACPE Evaluation Links:
2021
Educational Sessions from the 2020 Premier Alternate Site Programs Virtual National Meeting & Expo:
USP Compounding Chapter Updates: Focus on Your Assessment of Risk
Patricia C. Kienle, RPh, MPA, FASHP
- PowerPoint Presentation
- ACPE Evaluation Links:
Reducing Medication Burden in LTC During COVID-19: A Deprescribing Guide
Manju T. Beier, Pharm D., BCGP, FASCP
- PowerPoint Presentation
- ACPE Evaluation Links:
Policy Updates around Infection Prevention and Best Practices for Clinicals Surveillance
Shara Siegel, MS & Daisy Jackson, CIC
- PowerPoint Presentation
- ACPE Evaluation Links:
Chronic Pain Management Primer
J. Andrew Orr-Skirvin, Pharm D., BCOP
- PowerPoint Presentation
- ACPE Evaluation Links:
Update on the Pharmacologic Management of Hypertension in the Older Patient
Joseph Saseen, Pharm D.
- PowerPoint Presentation
- ACPE Evaluation Links:
Handling CBD and Medical Marijuana in the Non-Acute Setting
Soumi Saha, Pharm D., JD & T.J. Griffin
- PowerPoint Presentation
- ACPE Evaluation Links:
The COVID-19 Pandemic: What Worked, What Didn’t
Douglas Fish, Pharm D.
- PowerPoint Presentation
- ACPE Evaluation Links: